Public Health Alert for Frozen Pork and Beef Tortellini Product Due to Misbranding & Undeclared Allergens

Translate to Spanish or other 102 languages!

The U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) is issuing a public health alert for frozen product labeled as pork and beef tortellini due to misbranding and undeclared allergens. Image courtesy of FSIS
The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert for frozen product labeled as pork and beef tortellini due to misbranding and undeclared allergens. Image courtesy of FSIS
- Advertisement -

WASHINGTON – The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert for frozen product labeled as pork and beef tortellini due to misbranding and undeclared allergens. The frozen product labeled as pork and beef tortellini may actually contain pork and beef toasted ravioli, which contains soy and sesame, known allergens, which are not declared on the product label. FSIS is issuing this public health alert to ensure that consumers with allergies to soy and sesame are aware that this product should not be consumed. A recall was not requested because the products are no longer available for purchase.

The frozen product labeled as pork and beef tortellini that may contain pork and beef toasted ravioli was produced on May 27, 2025. The following product is subject to the public health alert [view labels]:

16-oz. bag “Schnucks Tortellini PORK & BEEF” with best by date of 05/27/2026 printed at the top of the bag.

- Advertisement -
Image courtesy of FSIS
Image courtesy of FSIS

The product subject to the public heath alert bears establishment number “EST. 13051” inside the USDA mark of inspection. The item was shipped to a Schnucks distribution center in Missouri and was further distributed to store locations in Illinois, Indiana, Missouri, and Wisconsin.

The problem was discovered when the establishment notified FSIS that their sole consignee received a consumer complaint of ravioli product in a bag labeled as tortellini.

There have been no confirmed reports of adverse reactions due to consumption of these products. Anyone concerned about a reaction should contact a healthcare provider.

FSIS is concerned that some product may be in consumers’ freezers. Consumers who have purchased these products are urged not to consume them. These products should be thrown away or returned to the place of purchase.

- Advertisement -

Media and consumers with questions regarding the public health alert can contact Jessica Fazio, Plant Manager of P. E. & F, Inc., at (314) 645-6239 ext. 230, or by email at jessica@faziosbakery.com.

Consumers with food safety questions can call the toll-free USDA Meat and Poultry Hotline at 888-MPHotline (888-674-6854) or send a question via email to MPHotline@usda.gov. For consumers that need to report a problem with a meat, poultry, or egg product, the online Electronic Consumer Complaint Monitoring System can be accessed 24 hours a day at https://foodcomplaint.fsis.usda.gov/eCCF/.

Information source: Food Safety and Inspection Service (FSIS

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

Summer Readiness: Keep Your Family Safe with These Heat Tips

The National Weather Service has several tips and warnings with summer temperatures hitting well over the 100-degree mark.

DHR Health To Host 20th Annual “Fishing for Hope” Tournament, August 22nd

DHR Health invites the community to cast a line for a cause at its 20th Annual Fishing for Hope Tournament. The event is set for August 22, 2026, at Jim’s Pier on South Padre Island.

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -